Accumulating evidences had demonstrated that CD24 was involved in epithelial–mesenchymal transition (EMT) and its increased expression was correlated with poor prognosis in patients of epithelial ovarian cancer [31,32]. Here, CD24 is linked to ovarian carcinoma.